Advertisement

Topics

Companies Related to "Efficacy of Treatment for Panic Disorder" [Most Relevant Company Matches] - Page: 5 RSS

16:29 EDT 23rd March 2019 | BioPortfolio

Here are the most relevant search results for "Efficacy of Treatment for Panic Disorder" found in our extensive corporate database of over 50,000 company records.

Showing "Efficacy Treatment Panic Disorder" Companies 101–125 of 3,600+

Probably Relevant

PURE Bioscience

PURE Bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including Staph (MRSA). PURE's proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today's ...


Synlogic™ Inc.

Synlogic™ is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, pioneering the development of a novel class of therapeutics, called Synthetic Biotics™, based on its proprietary synthetic biology and microbiome platform. Synlogic’s two lead therapeutic programs are being developed for the potential treatment of rare...

Viamet Pharmaceuticals Inc.

Viamet is a biopharmaceutical company focused on the discovery, development and commercialization of novel antifungal agents based on its proprietary metalloenzyme medicinal chemistry platform, the Metallophile® Technology. Metalloenzymes are enzymes that contain a metal, such as iron, zinc or copper, which is linked to the enzyme’s protein compone...


VirtuOx, Inc.

VirtuOx, Inc. is a privately held medical technology services company that provides diagnostic tools and services that enable a variety of healthcare organizations and professionals in diagnosing and treating Respiratory diseases through vertically integrated platforms, products and services. VirtuOx' platforms includes a Medicare approved, Independent Diagnostic Testing Facility (IDTF) that assi...

Orphan Medical Incorporated

Orphan Medical Incorporated is a development stage company, was formed to acquire, develop and market products of high medical value intended to address inadequately treated or uncommon diseases of well-defined patient populationstreated by health care specialists. A drug has high medical value if it offers a major improvement in the safety or efficacy of patient treatment and has no substantially...

Ember Therapeutics, Inc.

Ember Therapeutics is a product-focused company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease. Today’s rising epidemic of obesity and Type 2 diabetes coupled with the lack of innovation in the industry’s metabolic disorder treatment pipeline underscores the need for novel, ...

Biofrontera AG

Biofrontera AG is a biopharmaceutical company specializing in the development of drugs for the treatment of dermatological and inflammatory diseases. The Company has three product candidates in clinical development for four different clinical indications. The most advanced products are BF-200 ALA (Phase IIb/III) for actinic keratosis and condyloma; and BF-derm 1 (Phase II) for chronic, antihistami...

Nanobiotix

Nanobiotix is an oncology focused nanomedicine company developing an innovative nanoparticle technology. Nanobiotix is developing new tools for cancer which utilize a physical mode of action at the cellular level of the cancer cell. This disruptive approach may reshape future treatment opportunities. Cancer is one of the leading causes of death worldwide and accounted for 7.6 million deaths (a...

Intec Pharma Ltd.

Intec Pharma Ltd. is a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and s...

Update Pharma Inc.

Update Pharma Inc. is developing UPI-928, an agent developed in the 1980’s by Lederle Laboratories in 44 phase 1, 2 and 3 clinical trials, including 33 clinical trials at the National Cancer Institute. Despite an acceptable safety database of over 2,000 treated patients, over 70 peer reviewed clinical publications that demonstrated efficacy in leukemi...

Ember Therapeutics

Ember Therapeutics is a product-focused company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease. Today’s rising epidemic of obesity and Type 2 diabetes coupled with the lack of innovation in the industry’s metabolic disorder treatment pipeline underscores the need for novel, ...

Pacific Shores Medical Group

We are a specialized hematology and oncology practice providing state-of-the-art treatments for adult patients with any type of cancer or blood disorder. We have been in operation for 20 years, and we care for thousands of patients every year. Our practice includes 12 medical oncologists, 5 offices, and over 100 highly trained and experienced staff members. We offer the best current treatment opti...

Horizon Therapeutics, Inc.

Horizon Therapeutics, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of mild-to-moderate pain and arthritis. Horizon's clinical portfolio includes innovative combination therapies in early- and late-stage development that are designed to improve safety, efficacy and patient compliance. For more information about the ...

ReVIDA Recovery Centers

ReVIDA Recovery Centers, a comprehensive behavioral healthcare company that incorporates medication-assisted treatment (MAT) to treat opioid use disorder, empowers each patient to reclaim the life they once had before experiencing addiction. A committed member of the community at-large, ReVIDA is dedicated to working with first responders, public health of...

Eating Recovery Center

Eating Recovery Center is an international center providing comprehensive treatment for anorexia, bulimia, EDNOS and binge eating disorder. Under the leadership of Drs. Kenneth Weiner, Craig Johnson, Emmett Bishop and Ovidio Bermudez, programs provide a full spectrum of services for children, adolescents and adults that includes Inpatient, Residential, Par...

CureDuchenne Ventures LLC

CureDuchenne Ventures LLC collaborates with pharmaceutical and biotechnology companies to facilitate the development of drugs to treat Duchenne muscular dystrophy. CureDuchenne Ventures LLC was formed by CureDuchenne, a national nonprofit that has funded seven research projects that have advanced to human clinical trials. CureDuchenne has leveraged $100 mi...

Akili Interactive Labs, Inc.

Akili is building clinically-validated cognitive treatments and assessments that are delivered in an action video game interface. Leveraging medical-grade science and consumer-grade software technology, the company is seeking to produce a new type of medical product that can offer safe and effective scalable treatment and better monitoring for pa...

Epilepsy Advocate

Epilepsy is a chronic neurological disorder affecting approximately three million people in the U.S. -- making it as common as breast cancer. Anyone can develop epilepsy; it occurs across all ages, races and genders. Uncontrolled seizures and medication side effects pose challenges to independent living, learning and employment, so the goal of epilepsy treatment is seizure freedom with minimal si...

National Rosacea Society

Rosacea is a chronic disorder primarily of the facial skin, often characterized by flare-ups and remissions. It typically begins any time after age 30 as a redness on the cheeks, nose, chin or forehead that may come and go. Over time, the redness tends to become ruddier and more persistent, and visible blood vessels may appear. Bumps and pimples are a symptom, and in severe cases the nose may grow...

GANYMED Pharmaceuticals AG

GANYMED Pharmaceuticals AG is developing monoclonal antibody therapeutics against solid tumors, where current therapies are poor and where there is an overriding medical need. The therapeutic efficacy of current solid cancer therapeutics is severely limited, because their molecular targets are elevated in a subset of a particular cancer but they are also found widely in normal tissues. In contrast...

PLANTON GmbH

Infectious diseases are the most frequent causes of death. Microbial resistance to antibiotics is an increasing problem in medical treatment and thus an important focus in pharmaceutical research. PLANTON develops and produces a novel class of antiinfectiva – antimicrobial peptides. These molecules have a strong antibiotic efficacy and a special mechanism avoiding resistance of human pathogens. ...

ProUroCare Medical

Proprietary vision technologies advancing the safety and efficacy of medical diagnostics and therapeutics. ProUroCare Medical Inc. is an early-stage company that is developing innovative sensing and vision technologies to increase the safety and efficacy of medical diagnostics and therapeutic procedures. Currently, we are focused on products and technologies that use minimally invasive techniqu...

Lycera Corp.

Lycera Corp. is focused on the discovery and development of small-molecule immunomodulators for the treatment of immunologic diseases, including psoriasis, rheumatoid arthritis, lupus erythematosis, inflammatory bowel disease and transplant rejection. Originally founded by Dr. Gary Glick as a spin-out of the University of Michigan, Lycera is developing drug candidates that target two novel therape...

Cancer Be Glammed, LLC

Cancer Be Glammed, LLC was founded by Lisa Lurie, a breast cancer survivor and Ellen Weiss Kander, who underwent chemotherapy for a rare blood disorder. They believe cancer can be survived in comfort and style, and that wearing and using fashionable, comfortable and soothing products during treatment and recovery can have significant, positive impact on a ...

GreeneStone Healthcare Corp.

GreeneStone Healthcare Corp. (OTCBB: GRST) operates medical and healthcare clinics in Ontario, Canada. GreeneStone’s clinics serve to add overflow capacity to an increasingly stretched provincial healthcare system, and provide private alternatives to publicly available healthcare services. Its three current medical clinics (two in Toronto, along with ...


More From BioPortfolio on "Efficacy of Treatment for Panic Disorder"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks